Valentia Biopharma Overview

  • Founded
  • 2006
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Valentia Biopharma General Information


Provider of a novel drug discovery platform designed to generate a broad pipeline of first-in-class drugs. The company's novel drug discovery platform analyzes thousands of compounds and have a capacity to reproduce the process of massive molecule testing in vivo using Drosophila individuals enabling the development of additional drugs to treat human diseases.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Discovery Tools (Healthcare)
Primary Office
  • Parc Científic de la Universitat de València
  • C/Catedrático José Beltrán, 2
  • 46980 Valencia
  • Spain
+34 963 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Valentia Biopharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Feb-2016 Completed Out of Business
1. Early Stage VC 26-Jun-2008 Completed Startup
To view Valentia Biopharma’s complete valuation and funding history, request access »

Valentia Biopharma Executive Team (2)

Name Title Board Seat Contact Info
Rebeca Lucas Co-Founder & Chief Executive Officer
Manuel Perez-Alonso Ph.D Co-Founder & Scientific Director
To view Valentia Biopharma’s complete executive team members history, request access »